Search results
Reports of ‘Ozempic Personality’ Are Bubbling Up on Social Media—What to Know
Prevention via Yahoo News· 3 days agoCan Ozempic cause personality changes? Alan says that Ozempic can “potentially” cause personality...
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic...
Morningstar· 6 days agoCognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders ...
Bursts of beta rhythms implement cognitive control: Studying these bursts may improve understanding...
Medical Xpress· 4 days agoStudying these bursts would improve understanding of cognition and clinical disorders, researchers argue in a new review. Individual cells electrochemically transmit signals ...
Trump's criminal trials are accelerating the countdown clock on America's news media
Salon via Yahoo News· 14 hours agoHowever, Donald Trump’s worsening and much more severe challenges in memory, speech, cognition, and...
Neuroscientists warn of "cascading" Alzheimer's risk from these two habits
Newsweek· 1 day agoTwo common habits could be putting you at an increased risk of Alzheimer's and related dementias,...
Parkinson's: New treatment may help reduce motor symptoms
Medical News Today· 3 days agoPrasinezumab, a monoclonal antibody designed to target protein clumps in the brains of people with...
Bright Light, Sharper Mind: Lighting Affects Cognition - Neuroscience News
Neuroscience News· 4 days agoThe study utilized advanced 7 Tesla fMRI to show that higher levels of light improve cognitive...
Does a woman's heart health affect cognition in midlife?
Medical Xpress· 4 days agoCognition (measured as processing speed and working memory) was assessed annually or biennially over...
Can supplements really help prevent dementia?
The Telegraph via Yahoo News· 4 days agoBy 2025, it’s estimated that over one million people in the UK will have a diagnosis of dementia. It’s a sobering thought, but new research suggests that...
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial
WPRI Providence· 5 days agoActinogen Medical Limited (ASX: ACW) announces the full enrolment of 167 participants in the Company's XanaCIDD phase 2a clinical trial in patients with cognitive impairment in major depressive ...